Editor's Note: It seems we are learning about new medical applications for marijuana on an almost daily basis. A possible cure or treatment for Ebola? Based on this Money article, it seems that some may think this is a possibility.
Earlier this month, we reported that Ebola.com’s owner, a disease-obsessed domain name vendor called Blue String Ventures, was hoping to sell the URL for at least $150,000. Now, according to a report fromDomainInvesting.com, Ebola.com has been sold to a Russian company that is apparently focused on the marijuana business.
Filings with the Securities and Exchange Commission show Ebola.com was bought by Weed Growth Fund for $50,000 in cash and 19,192 shares of Cannabis Sativa, a Mesquite, Nevada-based recreational and medical marijuana company that trades on over-the-counter markets. Based on Cannabis Sativa’s current stock price, those shares are valued at roughly $164,000, making the overall transaction worth just over $200,000.
